Status:
COMPLETED
Echogenic Amniotic Fluid on Perinatal Outcome
Lead Sponsor:
Egymedicalpedia
Conditions:
Amniotic Fluid; Disorder
Eligibility:
FEMALE
20-35 years
Phase:
NA
Brief Summary
Amniotic fluid is the liquid that surrounds a developing fetus in the amniotic sac and is usually clear to pale yellow in color. Amniotic fluid composition is complex with many maternal and fetal cons...
Detailed Description
The sonographic appearance of amniotic fluid has been described as both anechoic and echogenic. The clinical significance of echogenic amniotic fluid remains undetermined. Increased echogenicity of th...
Eligibility Criteria
Inclusion
- Pregnant women aged between 20, 35 years.
- Near or Full-term pregnant women admitted for delivery.
- Reliable date of LMP.
- Delivered vaginally after spontaneous onset of labor or CS.
Exclusion
- Fetal congenital anomaly by ultrasound (anencephaly\& Down syndrome), IUGR or macrosomic fetuses.
- Multifetal pregnancy.
- Maternal co-morbidity (Diabetes mellitus, hypertension, cardiac diseases, renal diseases \& hemorrhagic diseases) .
- Maternal infection (Toxoplasmosis, Varicella zoster infection,…).
- Placental abnormality (abruption placenta \& placenta previa)
- Cases with normal amniotic fluid study with ultrasonography.
Key Trial Info
Start Date :
August 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 30 2023
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT05407571
Start Date
August 1 2022
End Date
August 30 2023
Last Update
September 8 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Al-Azhar University hospitals
Asyut, Egypt